NEI Research News

Researchers at the University of Missouri School of Medicine have discovered that the virus that causes COVID-19 can breach the blood-retina barrier with potential long-term consequences in the eye.

Dave Steele, AKA The Blind Poet, brought his metered message of hope and inspiration to the NIH campus.

A five-year grant will fund research investigating biological processes that contribute to defects in immune response in the eyes of those with diabetes and identify methods to reverse them.

About 79% of clinical trial participants experienced measurable improvement after receiving experimental, CRISPR-based gene editing that is designed to fix a rare form of blindness.

A gene previously implicated in the development of atherosclerotic lesions in coronary arteries could be key to understanding why many people don’t benefit from the most used therapy for neovascular age-related macular degeneration (AMD).

The National Eye Institute has worked with the editors-in-chief of 7 leading vision journals to create a new two-year program: the Council of Vision Editors Fellowship Program.

Researchers used an imaging technology called adaptive optics to identify rare cells that could help fill in the gaps in existing theories of color perception.

Researchers at the National Institutes of Health applied artificial intelligence (AI) to a technique that produces high-resolution images of cells in the eye. They report that with AI, imaging is 100 times faster and improves image contrast 3.5-fold.

Aqueous Humor Proteome Database includes comprehensive information on 1,683 proteins identified in aqueous humor--the fluid in the eye's anterior chamber.

UConn scientists find protein that stimulates regrowth of optic nerve cells.